biobide

FEBRUARY 2, 2024

Pediatric cancers exhibit differences at the genetic level compared to the same form of adult disease, which may influence the selected treatment. Zebrafish Pioneers Advance in Pediatric Cancer Research and Treatment Increasing the survival rate is the primary goal when screening for cancer drugs.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 124

Therapies Virus DNA Clinical Trials 124

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. The Ampligen EAP protocol is authorized to enroll up to 100 active trial participants, 20 of whom may be Long Haulers. All study subjects will receive the same Ampligen treatments. development pipeline for ME/CFS.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

DrugBaron

OCTOBER 17, 2022

Not long enough treatment? Examples, such as post-hoc analyses of failed trials, are today too numerous to even be notorious. In practice, this looks much more like a traditional pharma company than a biotech. Pharma companies, unlike most biotechs, actually sell something – and they are usually phenomenally good at it.

Pharma Companies 100

Pharma Companies Pharmaceuticals Drug Development Production 100

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Saama Technologies, Inc. , Source link.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

The Pharma Data

OCTOBER 20, 2020

When thinking of cancer treatment centers, you likely think of the MD Anderson Cancer Center in Houston, TX. But they know they’re not the only ones out there with innovative ideas for cancer treatment. . MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research.

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Vial

DECEMBER 8, 2023

As we look forward to 2024, several groundbreaking therapies are poised to radically change the landscape of ophthalmology, providing hope and improved treatment options for patients with ocular conditions. The trial is designed to evaluate the safety of a prospective RS1 gene replacement therapy, known as ATSN-201.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

JANUARY 17, 2021

Billions of dollars are poured into research each year, yet the push for effective treatment and hope for a cure is dashed time and again. This week another biopharma announced the disappointing news that their trial too had failed to make an impact on the devastating progression of Alzheimer’s. Vlad Coric, M.D.,

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

The Pharma Data

SEPTEMBER 14, 2020

Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain. Accelerating your clinical trial supply through digitalization.

Clinical Supply 52

Clinical Supply Clinical Trials Pharma Companies Trials 52

H1 Blog

MAY 10, 2023

Healthcare providers are often the first line of defense in ensuring that people receive the medical treatment they need. From being key opinion leaders (KOLs) for pharma treatments to providing resources outside of going to see a doctor, it’s time to recognize the role that nurses can play in contributing to better health outcomes.

Nurses 52

Nurses Doctors Pharma Companies Clinical Trials 52

Sygnature Discovery

DECEMBER 22, 2022

Sygnature Discovery joins four of the top ten global pharma companies, Cancer Research Horizons , Manchester Cancer Research Centre (MCRC) and over 20 Contract Research Organisations (CROs) to support innovation in oncology through the second Oncology Development Programme (ODP2).

Pharma Companies 52

Pharma Companies Clinical Trials Science Trials 52

Sygnature Discovery

DECEMBER 22, 2022

Sygnature Discovery joins four of the top ten global pharma companies, Cancer Research Horizons , Manchester Cancer Research Centre (MCRC) and over 20 Contract Research Organisations (CROs) to support innovation in oncology through the second Oncology Development Programme (ODP2).

Pharma Companies 52

Pharma Companies Clinical Trials Science Trials 52

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

H1 Blog

JUNE 26, 2024

In a recent interview, Daniel Perez, the Director and Global Head of Health Equity for Worldwide Clinical Trials shared insights on health equity from personal and professional experiences. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

The Open Targets Blog

OCTOBER 24, 2023

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. Although pharma companies can be competitive, this kind of tool will not generate any IP, and it saved us so much work that we knew it could be of real benefit to the community.

Bioinformatics 63

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 63

Advarra

JUNE 14, 2022

Often, low accrual or delays in clinical trials stem from an undersized pipeline of potential participants. When site staff must manually find participants for trials, or even when automated recruitment solutions don’t deliver as promised, it puts the trial’s viability at stake, with sites and sponsors in the hot seat.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Research 52

The Anticancer Fund

JUNE 7, 2022

This is another study that is strongly supportive of replication and further development, including clinical trial development. The rationale was based on preclinical data showing that hydroxychloroquine can inhibit resistance due to treatment-induced autophagy. Median PFS (9.25

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Advarra

JULY 19, 2022

Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The sponsor is the pharmaceutical company conducting the trial. Also consider CRO oversight, trial management, data handling and record keeping, as well as allocation of responsibilities.

Packaging 52

Packaging FDA Trials Regulations 52

Vial

FEBRUARY 19, 2024

I always had the concept of morbidity of medicine and trying to find treatments for patients that are safe and effective and doesn’t have a lot of side effects. As we put it in first in human (trials), and we saw responses, it was super exciting to be able to navigate the landscape and where to position it for the patient benefit.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

The Pharma Data

NOVEMBER 10, 2020

When a company engages a CRO, they most often turn over full control of their study or preclinical trials to this contractor – in other words, they “outsource” their research. There are many notable differences between a Contract Research Organization (CRO) and a Contract Vivarium (CV).

Marketing 52

Marketing Science Pharma Companies Research 52

H1 Blog

DECEMBER 11, 2024

These forecasts highlight the key changes poised to transform the healthcare and pharma landscapes. In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Additionally, well see a move to multi-indication trials to maximize profitability.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

OCTOBER 14, 2020

Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. Lanifibranor is believed to be the first drug candidate to be granted this status for the treatment of NASH since January 2015. 1. -- -->. -- [if lte IE 8]--> .

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. The purpose of research and development in the pharmaceutical industry is the incremental innovation of medicinal products and treatments. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

MAY 13, 2021

In this special report, I’m going to show you why researchers at Harvard University and the Massachusetts General Hospital in Boston are now praising a strange new pain treatment originally discovered on the International Space Station. Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

DECEMBER 30, 2020

In September 2020, the trials were halted to investigate a potentially severe side effect in a UK patient, transverse myelitis, an inflammation of part of the spinal cord. After a short break, the trial restarted in the UK and other parts of the world, but was delayed for much longer in the U.S. With a market cap of $1.6

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug Target Review

MARCH 13, 2025

Negative data is often much larger in size than published data because it includes raw data from failed experiments, clinical trials with no significant effect and studies with null results. Techbio companies have initiated this approach. This is an AI generated image. Despite these advances, significant challenges remain.

Drug Development 59

Drug Development Science Clinical Trials FDA 59

The Pharma Data

DECEMBER 16, 2020

During Phase III trials, one of the cohorts was administered one and a half doses, as opposed to two full doses. The goal will be to develop anti-SARS-CoV-2-specific dMAbs which could offer versatile capabilities to function as both a therapeutic and preventive treatment for COVID-19. AstraZeneca’s efficacy is at 70.4%.

Vaccine 52

Vaccine DNA Government Pharma Companies 52

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In Gilead v. Superior Court , No. A165558 (Cal. First Dist.), So the plaintiffs pivoted.

Production 64

Production Marketing Drugs Pharma Companies 64